(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -13.63%673.95M | -9.75%722.1M | -9.75%722.1M | -10.58%749.41M | -11.72%761.49M | -14.70%780.28M | -16.10%800.15M | -16.10%800.15M | -13.30%838.12M | -26.91%862.58M |
-Cash and cash equivalents | -13.63%673.95M | -9.75%722.1M | -9.75%722.1M | -10.58%749.41M | -11.72%761.49M | -14.70%780.28M | -16.10%800.15M | -16.10%800.15M | -13.30%838.12M | -26.91%862.58M |
-Accounts receivable | 26.36%32.08M | 30.39%43.08M | 30.39%43.08M | -38.89%41.9M | -42.87%32.63M | 19.25%25.39M | 66.42%33.04M | 66.42%33.04M | 35.23%68.58M | 269.73%57.12M |
-Accrued interest receivable | -27.08%3.34M | -14.56%3.83M | -14.56%3.83M | --3.3M | --4.74M | --4.59M | --4.48M | --4.48M | ---- | ---- |
-Other receivables | ---- | ---- | ---- | ---- | --662K | -89.67%496K | -94.01%331K | -94.01%331K | ---- | ---- |
Total current assets | -4.66%873.52M | -1.76%917.9M | -1.76%917.9M | -2.67%925.4M | -4.44%918.57M | -8.79%916.2M | -10.38%934.33M | -10.38%934.33M | -10.05%950.77M | -22.13%961.24M |
Non current assets | ||||||||||
-Accumulated depreciation | ---- | -24.34%-33.87M | -24.34%-33.87M | ---- | ---- | ---- | -23.57%-27.24M | -23.57%-27.24M | ---- | ---- |
-Long term equity investment | -8.42%16.2M | -12.41%16.27M | -12.41%16.27M | -14.82%16.59M | -12.37%16.95M | -15.13%17.69M | -64.87%18.57M | -64.87%18.57M | -64.42%19.48M | -63.36%19.35M |
Non current note receivables | -14.25%319K | 83.39%552K | 83.39%552K | 393.06%710K | 27.86%179K | 144.74%372K | 95.45%301K | 95.45%301K | 136.07%144K | 174.51%140K |
-Goodwill | -5.03%1.56B | -5.16%1.58B | -5.16%1.58B | -5.06%1.6B | -34.02%1.62B | -33.90%1.64B | -33.88%1.66B | -33.88%1.66B | -33.66%1.68B | 25.29%2.45B |
Regulatory assets | 15.11%60.45M | 16.23%74.59M | 16.23%74.59M | 4.27%71.5M | 7.59%61.46M | 25.88%52.52M | 45.74%64.17M | 45.74%64.17M | 35.23%68.58M | 108.46%57.12M |
Non current deferred assets | 52.96%19.82M | 97.40%21.1M | 97.40%21.1M | --18.99M | --16.96M | 69.59%12.96M | 91.22%10.69M | 91.22%10.69M | ---- | ---- |
Total assets | 2.07%10.96M | 15.78%15.38M | 15.78%15.38M | --12.49M | --11.78M | -3.08%10.74M | 26.32%13.29M | 26.32%13.29M | ---- | ---- |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | 4.42%7.07M | 4.91%6.94M | 4.91%6.94M | -0.87%6.86M | -1.59%6.7M | -81.80%6.77M | -13.31%6.62M | -13.31%6.62M | -7.66%6.92M | -3.94%6.81M |
-Current capital lease obligation | 4.42%7.07M | 4.91%6.94M | 4.91%6.94M | -0.87%6.86M | -1.59%6.7M | -7.64%6.77M | -13.31%6.62M | -13.31%6.62M | -7.66%6.92M | -3.94%6.81M |
-accounts payable | -16.43%29.18M | -9.36%33.5M | -9.36%33.5M | -43.74%39.24M | -42.25%42.42M | -5.19%34.92M | -5.83%36.96M | -5.83%36.96M | -0.21%69.75M | 99.26%73.46M |
-Total tax payable | -11.83%17.76M | -13.15%18.09M | -13.15%18.09M | -12.31%19.46M | -17.51%19.37M | -28.48%20.15M | -66.86%20.83M | -66.86%20.83M | -64.38%22.19M | -64.62%23.48M |
-Other payable | 13.04%18.53M | 19.14%18.53M | 19.14%18.53M | -38.44%18M | -34.35%17.37M | 41.27%16.39M | 57.69%15.56M | 57.69%15.56M | 39.50%29.23M | 106.35%26.45M |
Current accrued expenses | 597.65%9.5M | 29.76%3.13M | 29.76%3.13M | --5.36M | --943K | -75.36%1.36M | -48.78%2.41M | -48.78%2.41M | ---- | ---- |
Current deferred liabilities | -0.37%67.23M | -1.11%67.34M | -1.11%67.34M | 2.41%63.12M | 0.16%63.03M | 2.78%67.47M | 4.45%68.09M | 4.45%68.09M | -0.80%61.64M | 7.71%62.93M |
Current liabilities | 2.13%141.03M | -3.85%144.67M | -3.85%144.67M | 2.74%148.91M | -4.43%143.24M | -23.73%138.09M | -4.68%150.46M | -4.68%150.46M | -0.47%144.94M | 3.69%149.87M |
Non current liabilities | ||||||||||
-Long term debt | -8.42%16.2M | -12.41%16.27M | -12.41%16.27M | -14.82%16.59M | -12.37%16.95M | -15.13%17.69M | -19.37%18.57M | -19.37%18.57M | -21.82%19.48M | -15.88%19.35M |
Non current accrued expenses | -3.19%36.87M | -7.15%37.57M | -7.15%37.57M | -11.30%37.16M | -10.56%37.3M | -8.37%38.09M | -3.65%40.46M | -3.65%40.46M | -3.06%41.89M | 12.47%41.71M |
Preferred securities outside stock equity | 7.87%18.35M | 4.67%23.6M | 4.67%23.6M | --23.5M | --19.6M | -20.07%17.01M | -10.68%22.54M | -10.68%22.54M | ---- | ---- |
Total non current liabilities | 0.35%158.79M | -4.98%162.75M | -4.98%162.75M | 0.74%168.37M | -6.20%162.61M | -24.37%158.24M | -22.39%171.28M | -22.39%171.28M | -19.62%167.13M | -17.80%173.35M |
Shareholders'equity | ||||||||||
Share capital | -0.45%4.3B | 1.49%4.36B | 1.49%4.36B | 1.90%4.36B | 1.90%4.34B | 2.16%4.32B | 2.37%4.3B | 2.37%4.3B | 2.38%4.27B | 14.74%4.26B |
-common stock | -0.45%4.3B | 1.49%4.36B | 1.49%4.36B | 1.90%4.36B | 1.90%4.34B | 2.16%4.32B | 2.37%4.3B | 2.37%4.3B | 2.38%4.27B | 14.74%4.26B |
Additional paid-in capital | 7.55%211.99M | 8.03%213.92M | 8.03%213.92M | 8.79%209.17M | 19.97%205.68M | 33.61%197.11M | 59.98%198.02M | 59.98%198.02M | 121.87%192.26M | 165.01%171.44M |
Retained earnings | 22.51%1.61M | 15.81%1.58M | 15.81%1.58M | --1.22M | --1.15M | -6.80%1.32M | -10.78%1.37M | -10.78%1.37M | ---- | ---- |
Gains losses not affecting retained earnings | -61.22%-4.32M | -32.32%-4.05M | -32.32%-4.05M | 93.29%-337K | 57.67%-6.61M | 61.03%-2.68M | -214.19%-3.06M | -214.19%-3.06M | -278.68%-5.02M | -436.34%-15.62M |
Other equity interest | 16.34%15.01M | 21.76%14.81M | 21.76%14.81M | -58.32%14.14M | -57.63%13.36M | -10.39%12.9M | 35.73%12.16M | 35.73%12.16M | -3.38%33.93M | 283.45%31.53M |
Total equity | -4.57%2.51B | -3.51%2.58B | -3.51%2.58B | -3.77%2.6B | -24.93%2.61B | -26.01%2.63B | -26.28%2.67B | -26.28%2.67B | -26.06%2.71B | 7.25%3.48B |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.